Novel Associations of Multiple Genetic Loci with Plasma Levels of Factor VII, Factor VIII, and Von Willebrand Factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium

Background: Plasma levels of coagulation factors VII (FVII), VIII (FVIII), and von Willebrand factor (vWF) influence risk of hemorrhage and thrombosis. We conducted genome-wide association studies to identify new loci associated with plasma levels.

Methods And Results: The setting of the study included 5 community-based studies for discovery comprising 23 608 European-ancestry participants: Atherosclerosis Risk In Communities Study, Cardiovascular Health Study, British 1958 Birth Cohort, Framingham Heart Study, and Rotterdam Study. All subjects had genome-wide single-nucleotide polymorphism (SNP) scans and at least 1 phenotype measured: FVII activity/antigen, FVIII activity, and vWF antigen. Each study used its genotype data to impute to HapMap SNPs and independently conducted association analyses of hemostasis measures using an additive genetic model. Study findings were combined by meta-analysis. Replication was conducted in 7604 participants not in the discovery cohort. For FVII, 305 SNPs exceeded the genome-wide significance threshold of 5.0x10(-8) and comprised 5 loci on 5 chromosomes: 2p23 (smallest P value 6.2x10(-24)), 4q25 (3.6x10(-12)), 11q12 (2.0x10(-10)), 13q34 (9.0x10(-259)), and 20q11.2 (5.7x10(-37)). Loci were within or near genes, including 4 new candidate genes and F7 (13q34). For vWF, 400 SNPs exceeded the threshold and marked 8 loci on 6 chromosomes: 6q24 (1.2x10(-22)), 8p21 (1.3x10(-16)), 9q34 (<5.0x10(-324)), 12p13 (1.7x10(-32)), 12q23 (7.3x10(-10)), 12q24.3 (3.8x10(-11)), 14q32 (2.3x10(-10)), and 19p13.2 (1.3x10(-9)). All loci were within genes, including 6 new candidate genes, as well as ABO (9q34) and VWF (12p13). For FVIII, 5 loci were identified and overlapped vWF findings. Nine of the 10 new findings were replicated.

Conclusions: New genetic associations were discovered outside previously known biological pathways and may point to novel prevention and treatment targets of hemostasis disorders.

Citing Articles

Association of pulse pressure with hematoma expansion in patients with spontaneous supratentorial intracerebral hemorrhage.

Wang C, Lai S, Kang B, Lin Y, Cao C, Huang X Front Neurol. 2024; 15:1374198.

PMID: 38813243 PMC: 11133623. DOI: 10.3389/fneur.2024.1374198.

Application of genetic testing for the diagnosis of von Willebrand disease.

Seidizadeh O, Baronciani L, Lillicrap D, Peyvandi F J Thromb Haemost. 2024; 22(8):2115-2128.

PMID: 38762018 PMC: 11548015. DOI: 10.1016/j.jtha.2024.05.006.

Endothelial Protein C Receptor and Its Impact on Rheumatic Disease.

OHehir Z, Lynch T, ONeill S, March L, Xue M J Clin Med. 2024; 13(7).

PMID: 38610795 PMC: 11012567. DOI: 10.3390/jcm13072030.

COVID-19 host genetics and ABO blood group susceptibility.

Ellinghaus D Camb Prism Precis Med. 2024; 1:e10.

PMID: 38550941 PMC: 10953747. DOI: 10.1017/pcm.2022.12.

Clusterin knockdown has effects on intracellular and secreted von Willebrand factor in human umbilical vein endothelial cells.

Cox A, Liu A, Ng C PLoS One. 2024; 19(2):e0298133.

PMID: 38363768 PMC: 10871512. DOI: 10.1371/journal.pone.0298133.

References

Vossen C, Hasstedt S, Demers C, Rosendaal F, Bovill E . Linkage analysis for three coagulation factors clustering on chromosome 13q34: factor VII, factor X and protein Z. J Thromb Haemost. 2007; 5(6):1325-7. DOI: 10.1111/j.1538-7836.2007.02554.x. View

Fu J, Naren A, Gao X, Ahmmed G, Malik A . Protease-activated receptor-1 activation of endothelial cells induces protein kinase Calpha-dependent phosphorylation of syntaxin 4 and Munc18c: role in signaling p-selectin expression. J Biol Chem. 2004; 280(5):3178-84. DOI: 10.1074/jbc.M410044200. View

Folsom A, Cushman M, Heckbert S, Ohira T, Rasmussen-Torvik L, Tsai M . Factor VII coagulant activity, factor VII -670A/C and -402G/A polymorphisms, and risk of venous thromboembolism. J Thromb Haemost. 2007; 5(8):1674-8. DOI: 10.1111/j.1538-7836.2007.02620.x. View

Strachan D, Rudnicka A, Power C, Shepherd P, Fuller E, Davis A . Lifecourse influences on health among British adults: effects of region of residence in childhood and adulthood. Int J Epidemiol. 2007; 36(3):522-31. DOI: 10.1093/ije/dyl309. View

Servin B, Stephens M . Imputation-based analysis of association studies: candidate regions and quantitative traits. PLoS Genet. 2007; 3(7):e114. PMC: 1934390. DOI: 10.1371/journal.pgen.0030114. View

Lopez-Sagaseta J, Montes R, Puy C, Diez N, Fukudome K, Hermida J . Binding of factor VIIa to the endothelial cell protein C receptor reduces its coagulant activity. J Thromb Haemost. 2007; 5(9):1817-24. DOI: 10.1111/j.1538-7836.2007.02648.x. View

Hofman A, Breteler M, Van Duijn C, Krestin G, Pols H, Stricker B . The Rotterdam Study: objectives and design update. Eur J Epidemiol. 2007; 22(11):819-29. PMC: 2071967. DOI: 10.1007/s10654-007-9199-x. View

Broadbent H, Peden J, Lorkowski S, Goel A, Ongen H, Green F . Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet. 2007; 17(6):806-14. DOI: 10.1093/hmg/ddm352. View

Spiel A, Gilbert J, Jilma B . von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation. 2008; 117(11):1449-59. DOI: 10.1161/CIRCULATIONAHA.107.722827. View

10.

Vitart V, Rudan I, Hayward C, Gray N, Floyd J, Palmer C . SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet. 2008; 40(4):437-42. DOI: 10.1038/ng.106. View

11.

Ridker P, Pare G, Parker A, Zee R, Danik J, Buring J . Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet. 2008; 82(5):1185-92. PMC: 2427311. DOI: 10.1016/j.ajhg.2008.03.015. View

12.

Harris E, Weigel P . The ligand-binding profile of HARE: hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E. Glycobiology. 2008; 18(8):638-48. PMC: 2561176. DOI: 10.1093/glycob/cwn045. View

13.

Mcquillan R, Leutenegger A, Abdel-Rahman R, Franklin C, Pericic M, Barac-Lauc L . Runs of homozygosity in European populations. Am J Hum Genet. 2008; 83(3):359-72. PMC: 2556426. DOI: 10.1016/j.ajhg.2008.08.007. View

14.

Clayton D . Testing for association on the X chromosome. Biostatistics. 2008; 9(4):593-600. PMC: 2536723. DOI: 10.1093/biostatistics/kxn007. View

15.

Wiggins K, Smith N, Glazer N, Rosendaal F, Heckbert S, Psaty B . ABO genotype and risk of thrombotic events and hemorrhagic stroke. J Thromb Haemost. 2008; 7(2):263-9. PMC: 2946410. DOI: 10.1111/j.1538-7836.2008.03243.x. View

16.

Feng D, Tofler G, Larson M, ODonnell C, Lipinska I, Schmitz C . Factor VII gene polymorphism, factor VII levels, and prevalent cardiovascular disease: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2000; 20(2):593-600. DOI: 10.1161/01.atv.20.2.593. View

17.

Souto J, Almasy L, Borrell M, Gari M, Martinez E, Mateo J . Genetic determinants of hemostasis phenotypes in Spanish families. Circulation. 2000; 101(13):1546-51. DOI: 10.1161/01.cir.101.13.1546. View

18.

Girelli D, Russo C, Ferraresi P, Olivieri O, Pinotti M, Friso S . Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med. 2000; 343(11):774-80. DOI: 10.1056/NEJM200009143431104. View

19.

de Lange M, Snieder H, Ariens R, Spector T, Grant P . The genetics of haemostasis: a twin study. Lancet. 2001; 357(9250):101-5. DOI: 10.1016/S0140-6736(00)03541-8. View

20.

Hines L, Stampfer M, Ma J, Gaziano J, Ridker P, Hankinson S . Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med. 2001; 344(8):549-55. DOI: 10.1056/NEJM200102223440802. View